text: <unk>  is an asparginase that is FDA approved for the treatment of acute lymphoblastic leukemia (ALL) and acute lymphoblastic leukemia and hypersensitivity to asparaginase.   Common adverse reactions include allergic reactions (including anaphylaxis), central nervous system thrombosis, coagulopathy, elevated transaminases, hyperbilirubinemia, hyperglycemia, and pancreatitis.
option_0: Pegaspargase
option_1: Agalsidase beta
option_2: Brinase
option_3: Alglucerase
option_4: Laronidase
option_5: Glucarpidase
option_6: Isozyme
option_7: Idursulfase